Member Info for bignose58

I wonder just how much that study is costing ? Certainly a lot given it’s still ongoing and recommendations will not be available before May !!! Wonder why the market was not informed before that the study was in progress, given all the other operational updates we’ve received on Fortacin recently ?

Certainly an interesting read, although I was under the impression they had already had some third party investigate the price point some years back.

The.Italian, they only ref ED a fair amount as they have used this as a basis of the discussions with insurance companies. They don't mention PE in any instance, but instead use the product name "Fortacin", which, I am pretty sure is understandable to be a PE product (although admittedly, one can never tell with the incompetence of this crowd). it certainly is a lot better investigational work than what was done for the EU which they appear to have relied on Recordati for guidance.

Certainly good business sense (seems they have actually found some after all these years) which can be used as leverage as I understand they are in preliminary discussions with about 7 or 8 major players. I'm pretty sure any US licensee will be pretty aggressive when it comes to a deal (in their favour) and having feedback from the insurance companies themselves with a higher than expected price/can (although a pretty wide band 144 to 500 USD/can) and who is willing to cover the costs, could reap huge rewards. It also provides an indication of the agreed price point for China, which in itself appears pretty damned good for the region (96 to 333 USD/can) which is still 2.7 times the price in Europe.

As to whether its indicative of a license sale is anyone's guess. Given the positivity it represents in the US and China, this could have a real positive impact today and over the coming weeks on the companies SP which could just be used for a placing, although, given how close RPG is to receiving the 4mill from China (in the next few weeks) and the possibility of large upfront payments from US licensees with possible coverage of Phase III study, I am inclined to think not. But again, who knows what devious intentions could be going through the A teams mind..... :-)

Still highly positive none the less.............. Think I'd better get a new inner tube for the wheel barrow due to possible increased haulage weight, better sooner than later.....lol

Onwards and exponentially upwards........... lol

Heimdal,

I wouldn’t call it a strong finish given that it finished up 1% on 3 x 30k share and 1 x 10k share buys at 15:59:12. It certainly looks like some entity is playing with the sp. Exactly the same happened on Friday. Certainly a load of old bollingers if you ask me ;-)

Morning The.Italian. the way it is written would indicate its just a formality (the Company has been advised by Wanbang Pharmaceutical that the CTA will be obtained from the Center of Drug Evaluation within 60 working days) since they state "will" and not "may". (I'm sure they are all members of some Chinese secret society with funny handshakes etc........lol).

Remember, the submission has already been delayed for a year after, I would guess, a preliminary review was made which found missing paperwork from third parties. As such, the full submission probably just needed this corrected before being made and based on what was previously reviewed, they already have an indication, but they may need 60 days given how many other drugs need to be reviewed too. Just my take on the matter. I guess we could possibly receive a positive response before the 60 days, depends how busy they are....hopefully it happens before CNY on Feb 12, otherwise it'll be another few weeks???

Heimdal,

That's right. Luckily the management, even back then, were incompetent, which meant at least PLE holders got 65% of the company, although that % has gradually nearly been halved and taken back by the A team and their mates. Interesting they never mention any of this in updates and PR, but continue to provide misleading information to possible new investors. But then again, if prospective investors do their due diligence, they will easily see through the charade. Maybe that's why the company still has yet to attract any big players ? So we are currently at the mercy of brokers and day traders pushing the price up and then dragging it back down in a saw tooth fashion.

Hopefully this is indeed the turning point, although, as posted, it wont be anything to do with management business competence. As they say "time heals" and eventually some good must come out of it. it's just unfortunate pi's have been slowly diluted to **** whilst others are paid huge unwarranted salaries in doing so. (Remember the US license agreements have been effectively round the corner and at heads of terms since early 2014) and it continues.

So, it would seem 0.186 is the new support level....

Thanks for that Heimdal, however. Again, this statement “The Group has a strong track record of investments and has returned approximately US$298 million to shareholders in the 23 years of financial reporting since its initial public offering in May 1997” is utter rubbish and thoroughly misleading. Since 2015, the company is a completely different entity and so far the BOD have only lost money through bad investments and caused total destruction to the company’s and shareholder value.

Hopefully recent events will indeed start to turn this around, which won’t be because of an incompetent BOD.

Although a lacklustre trading day, one positive is that the sp never went below the opening price. As such, maybe 0.19 is the new support level. We will undoubtedly know if it’s sustainable tomorrow.

I was expecting an announcement prob this or next week, although today is so much better.

Seems the China syndrome may start sooner rather than later....with possible approval by the end of next year, which is much better (now I am wondering what the point of HK/Macau and waiting for Taiwan’s approval was all about)......that’s if there are no delays, although getting 150 sufferers in China is going to be much easier than getting the 100 for the FDA, which took 2 years !!! Even though phase 3, from what I understand, will only require 75 participants, it could still take 18 months based on how long 100 took. Can they use the same participants I wonder?

And that old nutshell again about upscaling to 50k cans. Since we had already been advised that upscaling was being actioned, 3 years ago and then again a couple of months ago, what are they trying to imply this time? That there will be two production lines with 50k can batches?? Certainly confusing. Certainly appears they have forgotten what they already told the markets .... again. ;-)

It will be interesting to see what reaction, if any, there is tomorrow.

I notice ANIC has been slowly creeping up since JM mentioned it in his webinaire last year, although I have my doubts that it will reach the 500 mill market cap he mentioned by mid 2021. I also notice oil hasn't reached the "over 100USD/barrel" which he also stated he expected by year end. (And totally unrelated, but interesting)Tesla seems to have done really well last year even with the lockdowns and pandemic. its gone from 90USD on the 6th Jan last year to 700USD today..... who would have thought.....(669bill usd).

And with respect to ANIC, a Singaporean restaurant started selling lab meat a couple of months ago (gov approved). The start of a new trend ??? I wonder where all those cows will be put ??? At least there will now be reduction in greenhouse cow a_rse gas....... since surely the number of cows must start to decline.....lol

The icing on the cake would obviously be if they could (and a company is willing to take it off their hands) sell the licenses for the remaining regions. (although I’m sure it would be far too troublesome to consider selling PLE to a single entity).

Now that certainly would be something... ;-)

Heimdal.

I wouldn't get too excited about the charts since, as we have witnessed before. Regents share price never follows any trend as neither does the Asian mind.... ;-)

I would suspect the SP will probably be much higher if they can get a US license agreement sorted (which will probably lead to the remaining regions also). I understand the wheels of which will be set in motion (if not already) once the official phase III commences. A couple of upfront payments could negate any need for further cash calls, which would seem crazy just after options had been awarded....no ?

I'm also hopeful that with Taiwan/HK/Macau approval, there will not be a requirement for additional clinical trials. Particularly since in so doing they would effectively going against a "One China" which has been in the media continuously this last year........ but, then again. They may just not because Orient is a Taiwanese company....who knows.... One can only but hope some logic prevails.

Happy new year Heimdal, hope you had a good one.

Thanks for the article, which is interesting, although we will be relying on Regents PR machine, which broke down a long long time ago, although the end of year profit waning will be released as usual.... lol

The Directors are pleased to announce that the Offer in respect of the Option to subscribe for
18,000,000 Shares has been duly accepted by the Grantee.

Right now that's done, lets get the phase II wrapped up so we can commence officially phase III and possibly get that/those remaining license agreements settled and or sell the license for a shed load of dosh.

I'm afraid, due to the dilution effects, I've had to cancel the forklifts and industrial mining trucks for a single wheelbarrow with flat tyre. ........ :-(

The.Italian,

I don't disagree with any of that, however. The current dilution of 35% gives the company what exactly ? 3.79mill USD which is already earmarked for DLI and if not, it just means it will run out a lot sooner than later.

I'm sure there are still many LTH's who have been invested for 12+years here and although one can be told to sell up and invest elsewhere, most invested because of the main product, which I believe has huge potential. The fact that the company cannot get it out there as per their own schedules and presentations is just incredible. The lies and non transparency they use to cover their mistakes is the stuff of fairytales.

I wouldn't mind a 35% dilution if money was raised to actually get the product out there to realise an income, but currently what they are doing is just disastrous. The whole thing could have been handled so much better and more professionally. After all those shares, the company as far as I can see still cannot afford the remaining AT bill.... how professional is that !!!

They cannot get their schedules right, so they get bored and start looking at other things with the same incompetence (CBD for example). If the so called management cannot get their main product right, how on earth can you expect them to get the longevity route right ? And there may be a few more people involved, but who do you think ultimately pulls the strings. The same person who has from the beginning. As I have stated before. I have yet to see him, in any of his recent ventures (in the last 10 years), make any money for the pi. Even his mates are being shafted.

Companies do indeed change strategies and direction when they find that a certain route doesn't work out, but in this case, we still have the product, its just incredible that everything they touch turns to ****e which is nothing to be proud of. Also, in this case they have a great product which will be a great earner, its just a pity they waste so much investors money on their own ego's. Huge unwarranted salaries and bad investments.

By the time any of this (DLI) comes to fruition how much of our investment has been demolished to "next to nothing"? So in fact what would appear to be valuable depends on how that value is viewed.

We would have been better off investing in a company run by Chimpanzees as I'm sure we would have, at least, gotten some bananas by now. ..... :-)

Another 7.6% dilution from last years convertible notes.

That's 35% total dilution to existing shareholders (DLI + CN's + Options).

That's an amazing return to LTH's............ I'd hate to see what would happen if they were not doing so well financially.... LOL

Oh and thanks, yet again, to POM for that...... ;-)

https://finance.yahoo.com/news/deep-longevity-adds-three-medical-104700288.html

Yet more collaborations........ No mention of any hard cash being received or licenses sold. Will this actually make RPG any money, particularly now when it is needed most ?

The.Italian,

It all reads as interesting, but what do they mean by “we attempted” that doesn’t read too positive. Surely they should have just written “we delivered”. Correct me if I’m wrong, but doesn’t that create a little negativity. It’s as if ppl were not that interested, irrespective as to what’s written further down.

I think they need to be a bit better in communication, unless it was written by JG.....lol

Anyway, thanks for posting.
Merry Christmas.

Keith,

No problem. We have all done it at one time or another. If only it was the wine :-)